Autoimmune hemolytic anemia (AIHA) is an acquired hemolytic disorder, mediated by auto-
antibodies, and has a variable clinical course ranging from fully compensated low grade …

In 2016, sepsis was newly defined as life-threatening organ dysfunction caused by a
dysregulated host response to infection. Sepsis remains one of the crucial medical problems …

Complement activation in the diseases paroxysmal nocturnal hemoglobinuria (PNH) and
atypical hemolytic uremic syndrome (aHUS) results in cytolysis and fatal thrombotic events …

Constructing multifunctional surfaces is one of the practical approaches to address catheter‐
related multiple complications but is generally time‐consuming and substrate‐dependent …

Complement-mediated (CM) autoimmune hemolytic anemia (AIHA) is characterized by the
destruction of red blood cells (RBCs) by autoantibodies that activate the classical …

Background Thrombosis may complicate autoimmune hemolytic anemia (AIHA), but its
predictors are still lacking, and no clear‐cut indications for anticoagulant prophylaxis are …

Three Laminaria japonica polysaccharides (LJPs) extracted via water extraction (LJP-W),
acid extraction (LJP-A), and enzymatic extraction (LJP-E) were used as raw materials to be …

Iron deficiency anemia has a high prevalence in children and has repeatedly been
implicated as a risk factor for arterial and venous thrombosis. As an effective therapy for iron …

Background and aims Hemolysis is a known risk factor for thrombosis resulting in critical
limb ischemia and microcirculatory disturbance and organ failure. Intravasal hemolysis may …

Excess labile heme, occurring under hemolytic conditions, displays a versatile modulator in
the blood coagulation system. As such, heme provokes prothrombotic states, either by …